Loading...
Indian Pharmaceutical Exporter · #9 for Kit · $5.5M export value · DGFT Verified
Micro Labs Limited is the #9 Indian exporter of Kit with $5.5M in export value and 193 verified shipments. Micro Labs Limited holds a 1.3% market share in Kit exports across 22 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
| 24 |
| 9.3% |
| RWANDA | $406.3K | 17 | 8.6% |
| NIGERIA | $349.1K | 7 | 7.4% |
| MADAGASCAR | $205.6K | 34 | 4.4% |
| ZIMBABWE | $186.4K | 23 | 3.9% |
| VIETNAM | $150.0K | 3 | 3.2% |
Micro Labs Limited exports Kit to 23 countries. The largest destination is VIETNAM, DEMOCRATIC REP. OF accounting for 16.9% of Micro Labs Limited's Kit shipments, followed by KENYA (15.4%) and TANZANIA (12.0%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HATAY PHARMACEUTICAL JOINT STOCK | VIETNAM, DEMOCRATIC REP. OF | $592.6K | 13 |
| LABOREX UGANDA LIMITED | UGANDA | $571.0K | 15 |
| LABOREX TANZANIA LTD | TANZANIA | $527.6K | 17 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $349.1K | 7 |
| E.P.DIS | FRANCE | $276.3K | 16 |
| M S LABOREX KENYA LIMITED | KENYA | $254.3K | 7 |
| DANANG PHARMACEUTICAL- | VIETNAM, DEMOCRATIC REP. OF | $240.3K | 6 |
| M/S LABOREX KENYA LIMITED | KENYA | $237.0K | 7 |
| WESSEX PHARMACEUTICALS (RWANDA) | RWANDA | $203.4K | 6 |
| OOO LIFE CELL LIMITED | FINLAND | $200.0K | 4 |
Micro Labs Limited supplies Kit to 61 buyers globally. The largest buyer is HATAY PHARMACEUTICAL JOINT STOCK (VIETNAM, DEMOCRATIC REP. OF), followed by LABOREX UGANDA LIMITED (UGANDA) and LABOREX TANZANIA LTD (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $57.8M worth of Kit through 15,000 shipments from 1048 suppliers to 191 countries, serving 3,293 buyers globally. Micro Labs Limited contributes $5.5M to this total, accounting for 1.3% of India's Kit exports. Micro Labs Limited ships Kit to 23 countries through 61 buyers.
Micro Labs Limited's average Kit shipment value is $28.5K per consignment, based on 193 shipments totaling $5.5M. The largest destination is VIETNAM, DEMOCRATIC REP. OF (16.9% of Micro Labs Limited's Kit exports).
Micro Labs Limited ranks #9 among 1048 Indian Kit exporters with a 1.3% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($7.8M), MERIL DIAGNOSTICS PRIVATE LIMITED ($5.6M), MICRO LABS LIMITED ($5.5M). Micro Labs Limited processed 193 shipments to 22 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| INORE-KIT (COMBIKIT OF LANSOPRAZOLE + TI | $200.0K | 4 |
| LANCID KIT ( (LANSOPRAZOLE 30MG CAPSULES, CLARITHROMYCIN 500MG TABS, AMOXICILLIN500MG CAPS ) ( 7X1KIT ) ( QTY - 51780 )PCS | $150.0K | 3 |
| ESOFAG KIT ( (Amloxicillin 1mg Tablets + | $149.3K | 6 |
| ESOFAG KIT ( (AMLOXICILLIN 1MG TABLETS +CLARITHROMYCIN USP ) ( 7X1KIT )PCS | $132.1K | 3 |
| INORE-KIT ( (Combikit Of Lansoprazole, T | $100.0K | 2 |
| BANUPYL-KIT ( (Combikit Of Lansoprazole, | $100.0K | 2 |
| ESOFAG KIT (AMLOXICILLIN 1MG TABLETS + C | $100.0K | 6 |
| ESOFAG KIT Amloxicillin 1mg Tablets +Clarithromycin USP 500mg tablets + esomeprazole 20mg tablets 7X1KIT QTY- | $94.6K | 2 |
| INORE-KIT (COMBIKIT OF LANSOPRAZOLE , TINIDAZOLE+ CLARITHROMYCIN ) (7X(2+2+2)PCS | $92.6K | 3 |
| BANUPYL-KIT (COMBIKIT OF LANSOPRAZOLE CAPS 30MG, TINIDAZOLE TABS 500MG + CLARITHROMYCIN 250MG TABS) (7X(2+2+2)PCS | $90.3K | 3 |
Micro Labs Limited exports 166 distinct Kit formulations including tablets, capsules, syrups, and combination drugs. The top formulation is INORE-KIT (COMBIKIT OF LANSOPRAZOLE + TI with 4 shipments worth $200.0K.
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | SANDOZ PRIVATE LIMITED | $7.8M | 175 | 28 | $44.6K |
| 8 | MERIL DIAGNOSTICS PRIVATE LIMITED | $5.6M | 645 | 64 | $8.7K |
| 9 | MICRO LABS LIMITED ★ | $5.5M | 193 | 22 | $28.5K |
| 1 | LUPIN LIMITED | $5.4M | 108 | 11 | $50.0K |
| 10 | AJANTA PHARMA LIMITED | $5.4M | 339 | 17 | $15.8K |
Micro Labs Limited ranks #9 among 1048 Indian Kit exporters. Average shipment value of $28.5K compared to the market average of $55.1K. The closest competitors by value are SANDOZ PRIVATE LIMITED and MERIL DIAGNOSTICS PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,763 | 18.4% |
| SAHAR AIR | 2,534 | 16.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,051 | 7.0% |
| DELHI AIR | 983 | 6.6% |
| NHAVA SHEVA SEA (INNSA1) | 901 | 6.0% |
| Bombay Air | 541 | 3.6% |
| JNPT/ NHAVA SHEVA SEA | 433 | 2.9% |
| CHENNAI AIR CARGO ACC (INMAA4) | 405 | 2.7% |
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
Micro Labs Limited exports 76 products worth $463.6M. Beyond Kit, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Kit — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 191+ countries, 3,293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Kit exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Kit. For current shipment-level data, contact TransData Nexus.